2018 International Congress » Parkinson's Disease: Non-Motor Symptoms

Date: Monday, October 8, 2018

Time: 1:15pm-2:45pm

Location: Hall 3FG

Meeting: 2018 International Congress

1:15pm-2:45pm: “Frequency of autonomic and cardiovascular abnormalities in Mexican patients with early Parkinson’s disease”

J. Balderas, A. Gonzalez (Mexico City, Mexico)

1:15pm-2:45pm: A detailed clinical study of pain in 1957 participants with Parkinson’s disease

M. Silverdale, C. Kobylecki, L. Kass-Iliyya, P. Martinez-Martin, D. Grosset, M. Hu, M. Lawton, S. Cotterill, R. Chaudhuri, H. Morris, F. Baig, N. Williams, L. Hubbard (Manchester, United Kingdom)

1:15pm-2:45pm: A Study of Pain in Parkinson’s Disease

S. Meenakshisundaram, B. Samivel, T. Sundaram, LN. Ranganathan (Chennai, India)

1:15pm-2:45pm: Altered amplitude of low-frequency fluctuations and functional connectivity in excessive daytime sleepiness in Parkinson disease

X. Wang, K. Zhang (Nanjing, China)

1:15pm-2:45pm: Apathy in Parkinson’s disease is associated with REM sleep behavior disorder

F. Ricordeau, M. Figorilli, A. Marques, T. Vidal, B. Beudin, B. Debilly, P. Derost, M. Puligheddu, F. Durif, M.L. Fantini (Clermont Ferrand, France)

1:15pm-2:45pm: Assessment of pain and its correlation with quality of life in Parkinson’s disease

K. Anand, A. Agrawal, P. Kumar (New Delhi, India)

1:15pm-2:45pm: Association between sleep duration and subsequent risk of Parkinson´s disease and survival: Data from NEDICES study

R. López-Blanco, A. Sánchez-Ferro, J. Benito-León, F. Bermejo-Pareja, E. de Pablo-Fernández (Alcalá de Henares, Spain)

1:15pm-2:45pm: Asymmetric olfactory deficit in H&Y stage-1 early onset Parkinson’s disease

J. Wang, R. Stanford, L. Spreen, T. Subramanian, Q. Yang (Hershey, PA, USA)

1:15pm-2:45pm: Autonomic Dysfunction in Parkinson’s Disease: Role of New Surrogate Markers

S. Menon R, A. Lutterotti (Ernakulam, India)

1:15pm-2:45pm: Blockade D1-like and D2-like dopamine receptors within nucleus accumbens attenuate hyperalgesia responses in a 6-OHDA induced parkinson’s disease rat model

L. Li, CJ. Mao, XQ. Zhang, F. Wang, CF. Liu (Su Zhou, China)

1:15pm-2:45pm: Burden of Eye disease in Parkinson’s disease (PD)

N. Butt, M. Khwaja, A. Chatterjee (Reading, United Kingdom)

1:15pm-2:45pm: Characterization of the gastrointestinal dysfunction in mice overexpressing the human mutation (A53T) of alpha-synuclein

S. Diwakarla, R. Constable, O. Artaiz, D. Finklestein, J. Berger, J. Furness (Melbourne, Australia)

1:15pm-2:45pm: Circadian modifications in Parkinson disease

S. Guo (Wuhan, China)

1:15pm-2:45pm: Clinical characteristics of frailty in Parkinson’s disease

M. Peball, P. Mahlknecht, M. Werkmann, K. Marini, F. Murr, H. Herzmann, H. Stockner, R. de Marzi, B. Heim, A. Djamshidian, P. Willeit, J. Willeit, S. Kiechl, M. Nocker, K. Mair, W. Poewe, K. Seppi (Innsbruck, Austria)

1:15pm-2:45pm: Clinical differences between Parkinson’s disease motor phenotypes. Results from the COPPADIS Study Cohort

I. Legarda Ramirez, B. Vives Pastor, M. Menéndez González, M. Blázquez Estrada, M. Seijo, M. Lage Castro, R. Vázquez Gómez, J. Ruíz Martínez, A. Bergareche Yarza, C. Valero, MM. Kurtis, JR. Pérez Sánchez, O. de Fábregues-Boixar, J. González Ardura, C. Prieto, C. Ordás Bandera, P. Mir, P. Martínez Martín, D. Santos García (Palma de Mallorca, Spain)

1:15pm-2:45pm: Clinical evaluation of insomnia in Parkinson’s disease and its effect on the quality of life of patients

M. Salokhiddinov. (Tashkent, Uzbekistan)

1:15pm-2:45pm: Clinical features of Parkinson’s disease with and without rapid eye movement sleep behavior disorder

Y. Liu, XY. Zhu, XJ. Zhang, Y. Feng, SH. Kuo, W. Ondo, YC. Wu (Shanghai, China)

1:15pm-2:45pm: Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease

O. Levin, O. Iakovleva, M. Poluektov (Moscow, Russian Federation)

1:15pm-2:45pm: Clinical subtypes of Parkinson’s disease based on nonmotor symptoms: A cluster analysis

X. Xu, P. Chan (Beijing, China)

1:15pm-2:45pm: Commonalities of prodromal non-motor symptoms between movement disorders

M. Moscovich, S. Heinzel, R. Postuma, R. Reilmann, T. Klockgether, H. Jacobi, G. Höglinger, D. Berg (Kiel, Germany)

1:15pm-2:45pm: Communication and Swallowing Disorders in People with Parkinson’s disease: A National Survey on Everyday Impacts and Service Access

M. Swales, D. Theodoros, A. Hill, T. Russell (St. Lucia, Australia)

1:15pm-2:45pm: Comorbid REM sleep behavior disorder and impulse control disorder symptoms in early parkinson’s disease: The PPMI cohort

M.L. Fantini, F. Durif, JC. Corvol, D. Weintraub, C. Caspell-Garcia (Clermont Ferrand, France)

1:15pm-2:45pm: Comparison of Treatment Effectiveness of Conventional Functional Training (CFT) to Occupational Therapy (OT) Multi-modal CASH Program (CASH) in Improving Non-motor Symptoms and Carer Stress of Parkinson’s (PD) Patient at Intermediate and Advanced State

T. Tang, R. Wong, C. Lau, A. Chan, D. Chan, X.L. Zhu, W.S. Poon, V. Mok (Hong Kong)

1:15pm-2:45pm: Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound

U. Walter, P. Tsiberidou, M. Kersten, A. Storch, M. Löhle (Rostock, Germany)

1:15pm-2:45pm: Depressive symptoms may predict the future development of freezing of gait in patients with Parkinson’s disease: Findings from a 5-year prospective study

T. Herman, S. Shema Shiratzky, L. Arie, N. Giladi, J. Hausdorff (Tel Aviv, Israel)

1:15pm-2:45pm: Distinct effects of apathy and dopamine on effort-based decision making in Parkinson’s disease

C. Le Heron, O. Plant, S. Manohar, Y. Ang, M. Jackson, G. Lennox, M. Hu, M. Husain (Oxford, United Kingdom)

1:15pm-2:45pm: Dopaminergic dysfunction and abnormal metabolic network activity in REM sleep behavior disorder

P. Wu, H. Yu, Z. Huang, C. Zuo (Shanghai, China)

1:15pm-2:45pm: Dyspnea in Parkinson’s disease: A biomarker of disease’s severity?

G. Baille, T. Perez, F. Machuron, L. Defebvre, C. Chenivesse, C. Moreau (Lille, France)

1:15pm-2:45pm: Early gastrointestinal dysfunction is predictive of faster progression in Parkinson’s disease

M. Camacho, J. Evans,, D. Breen, G. Cummins, R. Wijeyekoon, K. Scott, T. Stoker, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)

1:15pm-2:45pm: Early stage Parkinson’s disease phenotypes

J. Toledo, MC. Rodriguez-Oroz, W. Ondo (Houston, TX, USA)

1:15pm-2:45pm: Effect of bedtime levodopa/carpidopa/entacapone (Stalevo®) on sleep disturbance in patients with Parkinson’s disease with motor fluctuation

KW. Park, HS. Ryu, MS. Kim, NR. Choi, SJ. Chung (Seoul, Republic of Korea)

1:15pm-2:45pm: Effect of CDNF on non-motor symptoms like motivation, fear, stress and depression-like behavior

P. Stepanova, M. Voutilainen, E. Laakkonen, M. Airavaara, V. Voikar, P. Piepponen, R. Tuominen, M. Saarma (Helsinki, Finland)

1:15pm-2:45pm: Effect of medication on lexical tone production in Cantonese patients with Parkinson’s Disease

A. Chan, S. Chen, J. Shao, C.C. Zhang, I. Lam, S. Pang, V. Ngan, J. Tam, W.C. Yang, J. Ngan, S. Pinto (Hong Kong)

1:15pm-2:45pm: Effect of Urinary Dysfunction on Fatigue Syndrome in Parkinson’s disease

V. Datieva, O. Levin (Moscow, Russian Federation)

1:15pm-2:45pm: Efficacy of incobotulinumtoxinA in patients with sialorrhea, as assessed using the modified Radboud Oral Motor Inventory for Parkinson’s disease (mROMP): Results of the SIAXI study

W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, F. Pagan, B. Flatau-Baqué, J. Csikós, A. Blitzer (Wolfach, Germany)

1:15pm-2:45pm: Efficacy of liquid sinemet on non-motor symptoms in Parkinson’s disease

M. Danoudis, R. Iansek, C. Boon (Cheltenham, Australia)

1:15pm-2:45pm: Enhanced cingulate activity while anticipating pain – evidence for altered ‘top down’ processing of pain in PD

S. Martin, A. Jones, C. Brown, C. Kobylecki, M. Silverdale (Manchester, United Kingdom)

1:15pm-2:45pm: Evaluation of non motor fluctuations in Parkinson disease by a visual analogue scale in Surgical Candidates

JPh. Azulay, C. Brefel-Courbon, C. Tranchant, F. Fluchere, A. Eusebio, M. Vaugoyeau, C. Magnaudet, T. Witjas (Marseille, France)

1:15pm-2:45pm: Evaluation of Non-motor Symptoms of Parkinson’s Disease Patients in a Hong Kong Chinese population using the HK-NMSQuest

V. Luk, N. Cheung, WC. Fong, G. Chan, A. Chan, KW. Fong, J. Lo, M. Ismail, J. Li, F. Chan, S. Chan, C. Chau, C. Ho, K.F. Leung, J. Lui, C. Wong, D. Chau, B. Chee, CW. Woo (Kowloon, Hong Kong)

1:15pm-2:45pm: Evaluation of pain in Parkinson’s disease

B. Durmus, O. Yilmaz Kusbeci, I. Inci (Izmir, Turkey)

1:15pm-2:45pm: Evaluation of the Effect of STN-DBS on the Gastrointestinal Symptoms in Patients with Parkinson’s Disease via GIQLI

A. Yilmaz, E. Okuyucu, M. Ugur (Hatay, Turkey)

1:15pm-2:45pm: Factors Associated with Non-adherence to Pharmacotherapy in Patients with Parkinson´s Disease Who Take Three and More Daily Doses of Dopaminergic Drugs

I. Straka, M. Škorvánek, M. Grofik, K. Danterová, M. Minár, J. Benetin, P. Valkovič (Bratislava, Slovakia)

1:15pm-2:45pm: Fatigue and depression are predictors of the tremor form of Parkinson’s disease

E. Kolupaeva, I. Zhukova, M. Nikitina, N. Zhukova, A. Latypova, O. Izhboldina, I. Mironova, M. Zhestikova, M. Titova, J. Kislukhina (Tomsk, Russian Federation)

1:15pm-2:45pm: Flexed posture: Relationships with non-motor impairments and upper body activities in people with Parkinson’s disease

A. Forsyth, R. Joshi, N. Allen, C. Canning, S. Paul (Sydney, Australia)

1:15pm-2:45pm: Gastrointestinal Symptoms and Enteric Nerve Dysfunction in A53T Mice

R. McQuade, P. Rajasekhar, S. Diwakarla, R. Constable, D. Poole, J. Berger, D. Finkelstein, J. Furness (Melbourne, Australia)

1:15pm-2:45pm: Gender differences in olfactory dysfunctions in Sardinian patients affected by Parkinson’s disease

P. Solla, C. Masala, A. Cannas, G. Defazio (Cagliari, Italy)

1:15pm-2:45pm: Gut microbiota geography in Parkinson’s disease in the world

M. Hirayama, T. Maeda, T. Minato, M. Itoh, J. Takeda, T. Hamaguchi, M. Katsuno, K. Ohno (Nagoya, Japan)

1:15pm-2:45pm: Heart rate variability and Sympathetic skin response in Parkinson’s disease

M. Ben Djebara, A. Nasri, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (La Manouba, Tunisia)

1:15pm-2:45pm: Impact of injection guidance techniques on the efficacy and safety of incobotulinumtoxinA for sialorrhea

F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

1:15pm-2:45pm: Impact of Late-onset REM Sleep Behavior Disorder on the Symptoms of Parkinson’s Disease

Y. Saitoh, M. Murata, Y. Takahashi (Tokyo, Japan)

1:15pm-2:45pm: Improvement of Levodopa-Responsive Chronic Pain after STN-DBS in Parkinson’s disease

A. Gera, G. Pal (Chicago, IL, USA)

1:15pm-2:45pm: Impulse control disorders and compulsive behaviours in Parkinson’s disease. Results from the COPPADIS Study Cohort

S. Jesus Maestre, M. Labrador Espinosa, A. Adarmes Gómez, C. Mendez Barrio, JC. Martinez Castrillo, A. Alonso Cánovas, P. Sanchez Alonso, S. Novo Ponte, MG. Alonso Losada, N. Lopez Ariztegui, J. Segundo Rodriguez, MI. Morales Casado, I. Gaston, F. Lacruz Bescos, P. Clavero Ibarra, J. Kulisevsky, J. Pagonabarraga Mora, B. Pascual Sedano, P. Martinez Martín, D. Santos Garcia, P. Mir Rivera, G. Coppadis Study (Seville, Spain)

1:15pm-2:45pm: Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synuclenopathies

I. Martinez-Valbuena, R. Valenti-Azcarate, I. Amat-Villegas, M.M. Carmona-Abellan, I. Marcilla-Garcia, L. Alonso-Herrero, G. Marti-Andres, T. Tuñon-Alvarez, M.R. Luquin-Piudo (Pamplona, Spain)

1:15pm-2:45pm: Investigation of the incidences of non-motor symptoms in first-degree relatives and the spouses of patients with Parkinson’s disease

J.B. Liu, X.J. Zhang, C.F. Liu (Yangzhou, China)

1:15pm-2:45pm: Is Heart Rate variability a differential biomarker in REM sleep behavior disorder, Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy?

F. Bernhard, G. Mayer, K. Kesper, A. Bauer, A. Janzen, E. Sittig, W. Cassel, D. Vadasz, N. Mix, V. Ries, W. Oertel (Marburg, Germany)

1:15pm-2:45pm: Is REM sleep behavior disorder associated with excessive daytime sleepiness in military veterans with Parkinson’s disease?

A. Sarwar, S. Moore (Houston, TX, USA)

1:15pm-2:45pm: Is repetitive transcranial magnetic stimulation an effective tool to treat pain in Parkinson’s Disease?

M. Bonello, T. Nurmikko, M. Steiger (Liverpool, United Kingdom)

1:15pm-2:45pm: Levodopa and subthalamic stimulation do not have the same effect on subjective cost for distal and axial efforts in Parkinson’s disease

C. Atkinson-Clement, E. Cavazzini, C. Baunez, A. Zénon, S. Pinto, F. Fluchère, E. Robin, T. Witjas, JP. Azulay, A. Eusebio (Aix-en-Provence, France)

1:15pm-2:45pm: Listen to the heart: Do loud vagal rhythms disharmonize the autonomic symphony in Parkinson’s disease patients with the LRRK2 mutation?

C. Carricarte Naranjo, C. Marras, N. Visanji, D. Cornforth, L. Sanchez-Rodriguez, B. Schuele, S. Goldman, M. Estévez Báez, P. Stein, A. Lang, H. Jelinek, A. Machado García (Havana, Cuba)

1:15pm-2:45pm: Long-term efficacy and safety of incobotulinumtoxinA treatment for sialorrhea in Parkinson’s disease and other neurologic conditions

F. Pagan, W. Jost, A. Friedman, O. Michel, C. Oehlwein, J. Slawek, A. Bogucki, S. Ochudlo, M. Banach, B. Flatau-Baqué, J. Csikós, A. Blitzer (Washington, DC, USA)

1:15pm-2:45pm: Lottery choice task as a detect tool for PD patients with pathological gambling

W. Liu, R. Wu, J. Goh (Hualien, Taiwan)

1:15pm-2:45pm: Mind and Movement in Parkinson’s disease: An experience with yoga

S. Varanese, N. Modugno (Pozzilli, Italy)

1:15pm-2:45pm: Motor and non-motor symptoms of a 7.5-year prospective study of patients with Parkinson’s disease

A. Yoritaka, Y. Shimo, T. Hatano, N. Hattori (Saitama, Japan)

1:15pm-2:45pm: Multimorbidity predicts quality of life but not motor severity in early Parkinson’s disease

R. Gravell, G. Duncan, T. Khoo, D. Burn, A. Sayer, R. Barker, R. Lawson, A. Yarnall (Newcastle upon Tyne, United Kingdom)

1:15pm-2:45pm: Natural history of RBD in Parkinson´s disease and response to dopaminergic and non-dopaminergic antiparkinsonian treatment

M. Ruiz-Lopez, V. Bruno, ME. Freitas, R. Rajalingam, A. Chang, S. Fox, A. Lang (Toronto, ON, Canada)

1:15pm-2:45pm: Neuroprotective effect of exogenous melatonin on apoptosis of neuroadernergic neurons in a rat model of Parkinson’s disease

F. Yadolahi, M. Mehrpour (Tehran, Islamic Republic of Iran)

1:15pm-2:45pm: No differences in the total burden of non-motor symptoms between Parkinson’s disease and non-degenerative parkinsonism

E. Jaakkola, J. Joutsa, E. Mäkinen, T. Noponen, M. Pitkonen, R. Levo, T. Mertsalmi, F. Scheperjans, V. Kaasinen (Turku, Finland)

1:15pm-2:45pm: Non motor symptoms in parkinsonism: A cross sectional study

V. Kataria, V. Goyal (New Delhi, India)

1:15pm-2:45pm: Non-motor outcomes of subthalamic DBS in PD depend on the location of volume of activated tissue

JN. Petry-Schmelzer, H. Dafsari, M. Krause, T. Dembek, A. Keyoumars, A. Rizos, M. Silverdale, J. Evans, M. Barbe, G. Fink, P. Martinez-Martin, V. Visser-Vandewalle, A. Antonini, L. Timmermann, K. Ray-Chaudhuri (Cologne, Germany)

1:15pm-2:45pm: Non-Motor Symptom In Young Onset Parkinson Disease as a Cause of Pharmacoresistence In Epilepsy

M. Awadh (Birmingham, United Kingdom)

1:15pm-2:45pm: Non-motor symptoms in Parkinson’s Disease: Frequency, types and correlated factors compared to a group of healthy controls. Results from the COPPADIS Study Cohort

L. Planellas, M. Martí, P. Santacruz, A. Cámara, S. Jesus Maestre, F. Carrillo García, P. Mir, M. Aguilar, P. Pastor, J. García Caldentey, E. Estelrich Peyret, N. Caballol Pons, I. Legarda, B. Vives Pastor, J. Hernández Vara, G. Martí Andrés, I. Cabo, L. López Manzanares, M. Gallego-de-la-Sacristana, P. Martínez Martín, D. Santos García, G. COPPADIS STUDY (Barcelona, Spain)

1:15pm-2:45pm: Non-motor symptoms in patients with idiopathic and converted REM Sleep Behavior Disorder

P. Chan, W. Mao, XN. Liu, SQ. Zhan, H. Zhang, Y. Li (Beijing, China)

1:15pm-2:45pm: Non-motor symptoms of Parkinson’s disease: Evaluation of urinary disorders

K. Karbozova. (Bishkek, Kyrgyzstan)

1:15pm-2:45pm: Nonlinearities in outcome-specific hazard of motor and nonmotor long-term complications of Parkinson’s disease

P. Prange, T. Danaila, C. Laurencin, C. Caire, E. Metereau, H. Merle, E. Broussolle, D. Maucort-Boulch, S. Thobois (Bron, France)

1:15pm-2:45pm: Nursing diagnoses, outcomes and ICNP® interventions related to urinary dysfunction in Parkinson’s disease

M. Tosin, B. Oliveira (Santos-SP, Brazil)

1:15pm-2:45pm: Objective and quantifiable assessment of sleep in patients with Parkinson’s disease using a wearable sensor

A. Mirelman, I. Hilell, N. Omer, A. Thaler, M. Kestenbaum, O. Assais, A. Orr-Urtreger, M. Brys, J. Cedarbaum, J. Hausdorff, N. Giladi (Tel Aviv, Israel)

1:15pm-2:45pm: Objective intestinal dysfunction in REM sleep behaviour disorder

K. Knudsen, T. Fedorova, A. Hansen, M. Sommerauer, AM. Haase, M. Otto, K. Svendsen, K. Ostergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

1:15pm-2:45pm: Odor identification in PD patients and controls in Estonian cohort

I. Kalju, T. Toomsoo, K. Vender (Tallinn, Estonia)

1:15pm-2:45pm: Off-painfull state in Parkinson’s disease patients: A redflag of complulsive behavior. Data from a PET-FDG study

G. Albani, A. Cistaro, P. Fania, S. Margotti, V. Arena, A. Mauro (Verbania, Italy)

1:15pm-2:45pm: Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease – A cross-sectional study amongst patients in a tertiary movement center

S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

1:15pm-2:45pm: Pain is correlated with other motor and non-motor symptom in Parkinson’s disease

Y. Liu, X.Y. Zhu, X.J. Zhang, S.L. Yang, T.Y. Feng, Y.C. Wu (Shanghai, China)

1:15pm-2:45pm: Preclinical cardiovascular sympathoexcitatory effects of TD-9855, a novel norepinephrine transporter (NET) inhibitor in development for the treatment of symptomatic neurogenic orthostatic hypotension (nOH) in patients with primary autonomic failure

S. Hegde, M. Pulido-Rios, A. McNamara, J. Smith, W. Smith, J. Kanodia, D. Bourdet (South San Francisco, CA, USA)

1:15pm-2:45pm: Predictors and biomarkers of pain in newly diagnosed Parkinson’s disease patients during a two-year follow-up

S. Perez-Lloret, A. Sauerbier, C. Falup-Percurariu, M. Tinazzi, K.R. Chaudhuri (Buenos Aires, Argentina)

1:15pm-2:45pm: Preliminary Study of Depression in Parkinson’s Disease with Diffusion Tensor Imaging

C. Dejie, S. QuanXi, C. Shihuo (Yunfu, Guangdong, China)

1:15pm-2:45pm: Prevalence and relationship of non-motor symptoms of Parkinson’s disease with plasma uric levels

Y. Zubair, S. Oyakhire, S. Abdulrahaman, O. Medu, S. Bwala (Abuja, Nigeria)

1:15pm-2:45pm: Prevalence of non-motor symptoms in Parkinson’s disease and its impact on quality of life in a tertiary care center in India

M. Karri, B. Ramasamy, R. Kalidoss (Coimbatore, India)

1:15pm-2:45pm: Progression of sleep disorders spectrum in Parkinson’s Disease: A 5 year clinical longitudinal study

1:15pm-2:45pm: Proteomic analysis of tear-fluid reveals disease-specific patterns in patients with Parkinson’s Disease

M. Börger, S. Funke, F. Maass, A. Leha, AE. Roser, AK. Wüstemann, M. Bähr, F. Grus, P. Lingor (Göttingen, Germany)

1:15pm-2:45pm: Quality of Life in Parkinson’s Disease: Impact of Depression and Apathy

H. Nagayama (Tokyo, Japan)

1:15pm-2:45pm: Relationship between dysphagia severity and gait disturbance in Parkinson’s disease

C. Kobylecki, I. Shiderova, E. Michou (Salford, United Kingdom)

1:15pm-2:45pm: Restless legs syndrome in Parkinson’s disease patients: a comparative study on prevalence, clinical features, motor and non-motor symptoms

S.Y. You, J.S. Lee, S.M. Jeon, Y.W. Cho (Daegu, Republic of Korea)

1:15pm-2:45pm: Retinal and choroidal changes in autosomal recessive PD are similar to idiopathic PD

A. Colpak, A. Agin, G. Yalcin-Cakmakli, S. Kadayifcilar, A. Bilgic, B. Eldem, B. Elibol (Ankara, Turkey)

1:15pm-2:45pm: Safinamide and Rasagiline effect on motor fluctuation, sleep quality and daytime sleepiness in Parkinson’s Disease: A validated questionnaires study

C. Liguori, A. Stefani, N. Mercuri, M. Pierantozzi (Rome, Italy)

1:15pm-2:45pm: Screening performance of abbreviated versions of the UPSIT smell test

T. Joseph, S. Auger, L. Peress, D. Rack, A. Schrag, A. Noyce (London, United Kingdom)

1:15pm-2:45pm: Selection of odorants for diagnosis of Parkinson’s disease

O. Izhboldina, N. Zhukova, V. Alifirova, A. Latypova, I. Zhukova, .Uu. Mironova, M. Nikitina, E. Kolupaeva (Tomsk, Russia)

1:15pm-2:45pm: Sensory signs and neuropathic pain in advanced Parkinson’s disease under levodopa treatment

A.E. Elia, G. Devigili, M. Damasco, L.M. Romito, P. Soliveri, S. Rinaldo, M. Falsitta, R. Eleopra (Milan, Italy)

1:15pm-2:45pm: Serum Uric Acid Level and Its Relationship to Non-Motor Symptomatology in Parkinson’s disease

O. Odeniyi, N. Okubadejo, O. Ojo, M. Danesi (Lagos, Nigeria)

1:15pm-2:45pm: Sexual Dysfunction in Women with Parkinson’s Disease

A. Hannoun, A. Deb, K. Smith (Worcester, MA, USA)

1:15pm-2:45pm: Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treatment of Nocturia in adults with Parkinson’s disease

A. Batla, U. Uchiyama, S. Simeoni, C. Melbourne, M. Baldwin, L. DeMin, G. Gonzales, C. Haslam, M. Pakzad, S. Islam, S. Eriksson, K. Bhatia, J. Panicker (London, United Kingdom)

1:15pm-2:45pm: Skin Deposition of Pathological Alpha-Synuclein in Idiopathic REM-sleep Behavior Disorder and Parkinsonism

A. Al-Qassabi, TS. Tsao, S. Dziadek, A. Racolta, T. Kremer, C. Czech, K. Taylor, W. Zago, R. Postuma (Montreal, QC, Canada)

1:15pm-2:45pm: Sleep Disturbances and Quality of Life in People with Parkinson’s disease

U. Chotphoksap, D. Tan, S.B. Tan, EK. Tan, S. Wang, J. Chew, E. Poh, X. Chen, T.Y. Kam, K. Prakash (Singapore, Singapore)

1:15pm-2:45pm: Sleep, Fatigue and Health-related quality of life in a cohort of Parkinson disease patients

O. Ojo, N. Okubadejo, O. Odeniyi, N. Osemwegie, O. Oguntunde (Idi-araba, Nigeria)

1:15pm-2:45pm: Smooth muscle dysfunction in the gastrointestinal system in the 6-OHDA model of Parkinson´s Disease

P. Murillo, P. Aronsson, M. Winder, T. Carlsson (Gothenburg, Sweden)

1:15pm-2:45pm: Stigma and communication in people with Parkinson’s disease (PPD)

M. Bacigalupe (La Plata, Argentina)

1:15pm-2:45pm: Striatal dopamine transporter availability changes reflect gastrointestinal dysautonomia severity in early Parkinson’s disease

J. Hinkle, K. Perepezko, K. Mills, Z. Mari, A. Butala, T. Dawson, A. Pantelyat, L. Rosenthal, G. Pontone (Baltimore, MD, USA)

1:15pm-2:45pm: Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls

N. Barad, C. Sankhla (Mumbai, India)

1:15pm-2:45pm: Subjective and objective urinary dysfunction in parkinson’s disease and atypical parkinsonisms

Y. Lee, J. Kim (Seoul, Republic of Korea)

1:15pm-2:45pm: Subthalamic nucleus stimulation normalises effort-based decision-making in Parkinson’s disease

C. Atkinson-Clement, E. Cavazzini, A. Zénon, T. Witjas, F. Fluchère, C. Baunez, JP. Azulay, A. Eusebio (Aix-en-Provence, France)

1:15pm-2:45pm: Temporal evolution of biomarkers from healthy ageing, isolated REM sleep behavior to early Parkinson’s disease

B. Mollenhauer, M-L. Muntean, J. Zimmermann, K. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, WH. Oertel, F. Sixel-Döring, C. Trenkwalder (Kassel, Germany)

1:15pm-2:45pm: The association between pain and physical activity in people with Parkinson’s Disease (PD)

H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorafat (Irbid, Jordan)

1:15pm-2:45pm: The Clinical Research of Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder

Y. Wang, Z. Liang (Dalian, China)

1:15pm-2:45pm: The comparative clinical analysis of sleep patterns in patients with Amyotrophic Lateral Sclerosis and Parkinson’s disease

S. Shuang, Z. Liang (Dalian, China)

1:15pm-2:45pm: The difference of the change of finger surface temperature after short time cold stress test between Parkinson disease and Multiple system atrophy

M. Takahashi, A. Hagiwara, K. Abe, A. Inaba, S. Orimo (Tokyo, Japan)

1:15pm-2:45pm: The Effect of Sleep Deprivation on Short-Term Memory and Emotion of Rotenone Treated Zebrafish Model of Parkinson Disease

Y. Xiong, D. Lv, S. Wei, F. Wang, C. Liu (Suzhou, China)

1:15pm-2:45pm: The Gut Microbiota in a Canadian Parkinson’s Disease Cohort

M. Cirstea, E. Golz, B. MacVicar, B. Finlay, S. Cresswell (Vancouver, BC, Canada)

1:15pm-2:45pm: The hardest symptoms that bother patients with Parkinson’s disease before and 3 months after Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy

V. Vuletic (Rijeka, Croatia)

1:15pm-2:45pm: The phenomenology of visual hallucinations in Parkinson’s disease: A descriptive analysis of Myanmar and Thai patients

Z. Shwe, J. Sringean, E. The, W. Thit, R. Bhidayasiri (Yangon, Myanmar)

1:15pm-2:45pm: The Prevalence of Gastrointestinal Symptoms in Parkinson’s Disease Patients in Bethesda Hospital, Yogyakarta, Indonesia

A. Al Jody, R. Pinzon (Yogyakarta, Indonesia)

1:15pm-2:45pm: The pulmonary function and respiratory muscle strength tests of elderly people with Parkinson’s disease: A two-year observational study

R. Gonçalves, J. Neto, P. Cortêz, C. Silva, N. De Souza, E. Souza, T. Freitas, C. Barros, E. Leon, F. Sanchez, E. Andrade (Manaus, Brazil)

1:15pm-2:45pm: The role of DUODOPA Treatment on Non-Motor Symptoms, Specificly Autonomic Dysfunctions

H. Ekmekci, M. Gültekin, A. Mammadli, Ş. Öztürk (Konya, Turkey)

1:15pm-2:45pm: The subthalamic stimulation inhibit bladder contraction by modulating local field potential and monoamine in the medial prefrontal cortex

T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kuwabara (Chiba, Japan)

1:15pm-2:45pm: The validity of the Arabic King’s PD Pain Scale in people with Parkinson’s disease

H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorofat (Irbid, Jordan)

1:15pm-2:45pm: Total CSF alpha-synuclein is inversely associated with non-motor symptoms in a population of patients with Parkinson’s Disease

T. Schirinzi, G. Sancesario, G. Di Lazzaro, B. Biticchi, N. Mercuri, S. Bernardini, A. Pisani (Rome, Italy)

1:15pm-2:45pm: Traditional Chinese Medicine in treating for salivation and nocturia for patient with Parkinson’s disease

W. Pan, T. Liu, M. Wang, B. Qin (Shanghai, China)

1:15pm-2:45pm: Utilizing latent class analysis to explore the sleep disturbance subtypes in Parkinson’s disease patients

H.J. Yang, H.J. Kim, S.J. Kim (Ulsan, Republic of Korea)

1:15pm-2:45pm: Validation of a patient/caregiver questionnaire to evaluate nocturnal hypokinesia in Parkinson’s disease

R. Bhidayasiri, O. Jitkritsadakul, J. Sringean, P. Martinez-Martin, C. Anan, N. Kantachadvanich, R. Chaudhuri, N. Hattori (Bangkok, Thailand)

1:15pm-2:45pm: Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)

G. Hipp, M. Vaillant, P. Kolber, C. Pauly, L. Pavelka, D. Reiter, R. Krüger, J. Simons (Belvaux, Luxembourg)

1:15pm-2:45pm: Validation of the Hong Kong Chinese version of NMSQuest (HK-NMSQ)

V. Luk, N. Cheung, G. Chan, KF. Leung, NFJ. Lui, WW. Wong, I. Chan, C. Li (Kowloon, Hong Kong)

1:15pm-2:45pm: Validation of the new diagnostic criteria for fatigue in Parkinson’s disease

A. Mosejova, T. Merovova, I. Straka, V. Han, Z. Gdovinova, P. Valkovic, M. Skorvanek (Kosice, Slovakia)

1:15pm-2:45pm: Visual deficits of self-motion perception in Parkinson’s disease

S. Yakubovich, O. Halperin, S. Hassin, S. Israeli-Korn, A. Zaidel (Ramat Gan, Israel)

1:15pm-2:45pm: Visual hallucinations and autonomic burden are inversely associated with physical activity in PD

J. Hinkle, K. Perepezko, N. Fischer, Z. Mari, L. Marsh, G. Pontone (Baltimore, MD, USA)

1:15pm-2:45pm: Vowel characteristics associated with Parkinson’s disease in Cantonese

N. Leung, E. Tong, M. Ng (Pokfulam, Hong Kong)

1:15pm-2:45pm: Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson’s disease

KJ. Pak, HK. Shin, EJ. Kim, JH. Lee, CH. Lyoo, JS. Son, MJ. Lee, HJ. Son (Busan, Republic of Korea)

1:15pm-2:45pm: α-synuclein propagation via olfactory pathway in non-human primate model

M. Sawamura, H. Onoe, N. Uemura, T. Isa, R. Takahashi (Kyoto, Japan)

« View all sessions from the 2018 International Congress.